Answers are grounded in this paper and cite their sources.
Ceftriaxone and lansoprazole are commonly used in clinical settings, but recent analyses indicate a potential risk for QTc prolongation and cardiac events when used together. This case series examines three patients from a cohort of sudden death cases at a single institution over a decade, who received both medications within 24 hours before death. Three cases were identified, each with contributing factors for cardiac arrhythmias. The results underscore the importance of monitoring and possibly avoiding this drug combination in patients at risk of QT prolongation, pending further investigation into the underlying mechanisms.
No takes yet. Share an insight, caveat, or question.
Harada et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: